The Global Aspiration & Biopsy Needles Market size was USD 875.3 Million in 2021 and is expected to register a revenue CAGR of 6.8% during the forecast period, according to latest analysis by Emergen Research. Rising prevalence of cancer cases owing to various lifestyle changes, rapid urbanization and rising pollution levels, and changing consumption habits and increasing cancer awareness programs and screening and tests by governments and various global health organizations are some of the key factors driving global aspiration and biopsy needles market revenue growth. According to World Cancer Research Fund International, around 18,094,716 million cases of cancer were diagnosed in 2020.
Request a sample copy of the report @ https://www.emergenresearch.com/request-sample/1015
Countries with populations having the highest life expectancy, high standard of living, and education level have higher cancer rates as per International Agency for Research on Cancer. However, for certain cancer such as cervical cancer, the incidence rate is highest in countries with low life expectancy. Growing pollution and tobacco smoking are some of the factors contributing to the increase in cancer rates as well. According to the National Cancer Institute (NCI), which is a principal agency for cancer research of the U.S. government, the most common cancers are breast cancer, lung cancer, thyroid cancer, prostate cancer, colon and rectum cancer, liver cancer, kidney cancer, leukemia, pancreatic cancer, and bladder cancer. Prostate, colorectal, and lung cancers account for around 43% of all cancer cases in men while breast, colorectal, and lung cancers has been expected to register around 50% of all new cancer cases diagnosed in women in 2020.
Growing preference for minimal invasive surgeries than open and closed surgical biopsies is a major factor expected to drive market growth. Provision of faster and more accurate and reliable diagnosis of tumors in a resource-restrained setting with minimal requirement of instruments is boosting demand for aspiration & biopsy needles, especially in highly populated and emerging countries. Cost-effectiveness and accessibility of aspiration and biopsy needles are contributing significantly to revenue growth of the market. Ease of detection of cysts, enlarged lymph nodes, and nodules in addition to lower risk of complications are increasing demand for Fine-Needle Aspiration (FNA) in various healthcare settings and diagnostic centers. Furthermore, rapid technological advancements and high value healthcare funding are increasing testing for cancer with needle-based biopsy instruments, which is expected to significantly boost revenue growth of the segment during the forecast period.
Purchase this report at an exclusively discounted rate @ https://www.emergenresearch.com/request-discount/1015
However, risk of infections and needlestick, and lack of availability of well-trained radiologists and surgeons are some of the key factors expected to drive reluctance among potential patients to some extent over the forecast period.
Some Key Highlights From the Report
Biopsy needles segment accounted for largest revenue share in 2021. High accuracy and less invasive in obtaining tissue samples for diagnosis are major factors expected to continue to drive revenue growth of this segment over the forecast period. Growing preference for minimally invasive diagnostic procedures over conventional methods attributes to the rapid adoption of segment. Biopsy needles enable accurate examination of tissue and identification of other conditions such as inflammatory, infections, and autoimmune disorders. Provision of performing procedures in outpatient settings with minimal requirements of preparation is a major factor driving demand for biopsy needles, especially in resource-restrained countries.
Image-guided segment is expected to register a steady revenue growth rate during the forecast period. Ease of detection as image-guided needle biopsy enables doctors to inspect suspicious areas that cannot be felt through the skin or are easily visible. This is a key factor driving high demand for image-guided biopsy needle procedures. Rising preference for minimally invasive biopsy is a major factor supporting growth of this segment.
Cancer/tumor segment is expected to account for a significantly large revenue share over the forecast period. Rapid urbanization and industrial development, and rising pollution levels and emissions are contributing to increasing number of health disorders and prevalence of cancers thereby increasing the demand for treatments. Rising awareness regarding various cancers is another factor driving revenue growth of this segment, especially since the pandemic increased need for screening and testing. Rising cases of suspicious lesions is also increasing need for faster pathological confirmation of malignancy for proper treatment. According to World Health Organization (WHO), in 2020, around 2.3 million women were diagnosed with breast cancer, and 685,000 death were recorded globally.
Asia Pacific accounted for largest revenue share in the global aspiration & biopsy needles market in 2021, owing to increasing healthcare investments and on infrastructure modernization, and cancer awareness initiatives by various governments. Increasing cancer diagnostics and screening initiatives by government and insurance organizations coupled with increasing research activities are factors boosting growth of the market. Increasing per capita income and rapid industrialization in emerging economies such as China, India, and South Korea are likely to open-up high-growth prospective for companies operating in the Asia Pacific aspiration & biopsy needles market.
Some major companies in the global market report include Argon Medical Devices, Inc., Boston Scientific Corporation, BD (Becton, Dickinson and Company), Cardinal Health, Conmed Corporation, Dr. Japan Co., Merit Medical Systems, Cook Group, Olympus Corporation, Hakko Co., Ltd., and Inrad Inc.
On 8 January 2019, IZI Medical Products, LLC, which is a leading interventional technology medical device company and portfolio company of Shore Capital Partners, LLC., acquired select soft tissue biopsy and breast localization needle assets from Cook Medical. Acquisition is expected to add a world-class portfolio of minimally invasive diagnostic and therapeutic products for the interventional radiology market.
Emergen Research has segmented the global remote access solutions market on the basis of product, procedures, application, and region:
Product Outlook (Revenue, USD Million; 2019-2030)
Vacuum-Assisted Biopsy (VAB) needles
Core-Needle Biopsy (CNB) needles
Procedures Outlook (Revenue, USD Million; 2019-2030)
Application Outlook (Revenue, USD Million; 2019-2030)
Bone & bone marrow cancer
Regional Outlook (Revenue, USD Million; 2019-2030)
Rest of Europe
Rest of APAC
Rest of LATAM
Middle East & Africa
Rest of MEA
Request customization of the report @ https://www.emergenresearch.com/request-for-customization/1015
Global Aspiration and Biopsy Needles Market Highlights:
Regional demand estimation and forecast
Product Mix Matrix
Pre-commodity pricing volatility
Supply chain optimization analysis
Technological updates analysis
Raw Material Sourcing Strategy
Mergers & Acquisitions
Location Quotients Analysis
Carbon Footprint Analysis
Besides offering a vivid depiction of the global Aspiration and Biopsy Needles business sphere and its fundamental operations, the latest report provides the industrial chain analysis and list down the current and future market trends and growth opportunities.
The report includes information on the present and historical market scenarios, which helps forecast the market conditions over the next eight years (2021-2030).
The report scrutinizes the salient factors influencing the growth of the market in the near future.
The strategic marketing recommendations, crucial information related to the new market entrants, and expansion plans of various businesses are poised to provide the reader with a competitive edge in the market.
Click here to Buy Now @ https://www.emergenresearch.com/select-license/1015
Thank you for reading our report. If you have any requests for customization of the latest report, kindly get in touch with us. Our team will assist you and ensure the report is designed as per your requirements.
About Emergen Research
At Emergen Research, we believe in advancing with technology. We are a growing Marketresearch and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Company Name: Emergen Research
Contact Person: Eric Lee
Email: Send Email
Phone: +1 (604) 757-9756
Address:14671 110 Avenue Surrey, British Columbia, V3R2A9
State: British Columbia